CGH
SYNH

Crossmark Global Holdings’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Crossmark Global Holdings’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,237
Closed -$392K – 1327
2023
Q2 		$392K Sell
9,237
-211
-2% -$8.53K 0.01% 950
2023
Q1 		$336K Buy
9,448
+69
+0.7% +$2.5K 0.01% 998
2022
Q4 		$344K Sell
9,379
-701
-7% -$27.7K 0.01% 961
2022
Q3 		$475K Sell
10,080
-110
-1% -$7.11K 0.01% 789
2022
Q2 		$731K Sell
10,190
-60
-0.6% -$4.39K 0.02% 663
2022
Q1 		$830K Buy
10,250
+250
+3% +$21.1K 0.02% 693
2021
Q4 		$1.03M Sell
10,000
-4,170
-29% -$400K 0.02% 620
2021
Q3 		$1.24M Buy
14,170
+220
+2% +$19.9K 0.03% 545
2021
Q2 		$1.25M Buy
13,950
+1,040
+8% +$87.9K 0.03% 538
2021
Q1 		$979K Buy
12,910
+820
+7% +$61.8K 0.02% 603
2020
Q4 		$824K Buy
12,090
+3,420
+39% +$213K 0.02% 629
2020
Q3 		$461K Buy
8,670
+50
+0.6% +$2.98K 0.01% 804
2020
Q2 		$502K Buy
8,620
+800
+10% +$43K 0.01% 754
2020
Q1 		$308K Sell
7,820
-20
-0.3% -$1.17K 0.01% 832
2019
Q4 		$466K Buy
7,840
+2,560
+48% +$138K 0.01% 837
2019
Q3 		$281K Sell
5,280
-180
-3% -$9.24K 0.01% 1088
2019
Q2 		$279K Sell
5,460
-160
-3% -$7.45K 0.01% 1134
2019
Q1 		$291K Sell
5,620
-40
-0.7% -$1.94K 0.01% 1141
2018
Q4 		$223K Buy
5,660
+240
+4% +$11.2K 0.01% 1243
2018
Q3 		$279K Buy
5,420
+170
+3% +$8.32K 0.01% 1368
2018
Q2 		$246K Buy
+5,250
New +$217K 0.01% 1435
2018
Q1 		– Sell
-5,350
Closed -$233K – 1638
2017
Q4 		$233K Sell
5,350
-3,230
-38% -$151K 0.01% 1517
2017
Q3 		$449K Buy
+8,580
New +$478K 0.01% 1030
2016
Q3 		$449K Buy
+8,580
New +$372K 0.01% 1030

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Crossmark Global Holdings's SYNH Position: Q3 2023 in Review

Crossmark Global Holdings sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 9,237 shares — an estimated $392K sold.

Crossmark Global Holdings first reported a position in SYNH in Q3 2016 and held it in 24 quarters. The position peaked at $1.25M in Q2 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Crossmark Global Holdings reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Crossmark Global Holdings sold 9,237 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $392K.
  • Crossmark Global Holdings first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2016 and held it in 24 quarters.
  • Crossmark Global Holdings's Syneos Health, Inc. Class A Common Stock position peaked at $1.25M in Q2 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Crossmark Global Holdings's 13F filing for Q3 2023, filed 8 Nov 2023.